Dr Reddy’s

The Street may see volatility ahead of exit polls that will be announced later in the day. On the international front, all eyes are on the US Federal Reserve that which may raise rates due to strong private payrolls. Dr Reddy's will be on investors' radar after it received 13 observations for its unit by the US drug regulator.

NSE FinWiz visits Dr Reddy's Hyderabad campus

Watch NSE FinWiz Season 4 visits Dr Reddy's Hyderabad campus to help the employees with their personal finance goals.

Good Q3 but Dr Reddy's still far from sustainable growth: Expert

Surajit Pal, Research Analyst at Prabhudas Lilladher, said the pharma sector is undergoing a transition and all the large midcaps will underperform.

Nifty remains below 8300, Sensex volatile; ONGC, Dr Reddy's soar

The volatility continued in noon trade after the Nifty reclaimed 8300 level. Oil and banking & financials stocks continued to support the market but the sell-off in technology stocks weighed.

FIPB clears FDI proposals worth Rs 94 cr

The Board also cleared proposals of M/s Quintillion Business Media Pvt. Ltd and M/s BMJ Group lndia Pvt Ltd.

Sensex, Nifty end flat; IT index gains 2%, ITC & Cipla fall 3%

TCS, Asian Paints, Maruti, Bajaj Auto and Infosys are top gainers while Dr Reddy's Labs, Cipla, Lupin, ITC and ICICI Bank are losers in the Sensex.

Dr Reddy's launches Raloxifene hydrochloride tablets in US

Dr Reddy's Laboratories has launched raloxifene hydrochloride tablets in 60 mg, a therapeutic equivalent generic version of Evista tablets, in the United States market.

Dr Reddy's joins hands with Gland Pharma to mkt 8 ANDAs in US

Dr Reddy's Laboratories on Wednesday said it has entered into a collaboration with Gland Pharma to market and distribute a diverse portfolio of eight injectable Abbreviated New Drug Applications (ANDAs) in the US market.

Nifty hits 8650, Sensex up 200 pts; Dr Reddy's dives 10%

BHEL, ICICI Bank, Maruti, Tata Motors and SBI are top gainers in the Sensex. Dr Reddy's dived 10 percent while Sun Pharma, Bajaj Auto and Lupin are other losers.

Nifty opens above 8150, Sensex gains over 150pts;HDFC, Maruti up

Dr Reddy's Labs, Tata Motors, HDFC, Maruti and Tata Steel are top gainers in the Sensex.

Nifty struggles below 8250, Sensex wobbles; NTPC, Reliance up 2%

NTPC, Reliance, ONGC, Tata Steel and GAIL are top gainers while Infosys, Dr Reddy's Labs, HUL, ITC and Bajaj Auto are losers in the Sensex.

Nifty hits 8100 in June series, Sensex up over 200pts; SBI up 2%

Sun Pharma, Lupin, SBI, Adani Ports and Cipla are top gainers while Tata Motors, ITC, BHEL, NTPC and Bharti Airtel are losers in the Sensex.

Sensex skids over 150 pts, Nifty weak; SBI, HUL down 2%

Hindalco, Tata Steel, Dr Reddy's Labs, Sun Pharma and ONGC are top gainers while SBI, ICICI Bank, NTPC, HUL and Bajaj Auto are major losers in the Sensex.

Sensex, Nifty remain sluggish; Dr Reddy's, Tata Motors up

Dr Reddy's Labs, Tata Motors, Lupin, Tata Steel and Vedanta are top gainers while BHEL, Axis Bank, Bahrti Airtel, GAIL and Sun Pharma.

Nifty struggles to hold 8100, Sensex up; Infosys, BHEL drag

Tata Motors, GAIL, Coal India, Cipla and Dr Reddy's Labs are top gainers in the Sensex. Among the losers are BHEL, Infosys, HDFC twins and Bajaj Auto.

Sensex skids over 100 pts, Nifty weak; Vedanta, BHEL down

ONGC, Bharti Airtel, Dr Reddy's Labs, Lupin and Wipro while Vedanta, Bajaj Auto, BHEL, TCS and Tata Steel are among laggards in the Sensex.

Nifty holds 8550; Dr Reddy's up 3%, ITC drags 2%

Dr Reddy's Labs, Lupin, Sun Pharma, Cipla and Infosys are top gainers while ITC, Tata Steel, ICICI Bank, Hero and HDFC Bank are among laggards in the Sensex.

Nifty ends July F&O series at 8422, Sensex firm; FMCG zooms

The Nifty closed July series below the 8450 level. The 50-share index was at 8421.80, up 46.75 points or 0.6 percent. The Sensex gained 141.92 points or 0.5 percent at 27705.35.

Sensex rises over 150 pts, Nifty nears 8500; Lupin, BHEL up

ONGC, Lupin, HDFC, Tata Steel and BHEL are top gainers in the Sensex while Dr Reddy's, NTPC, TCS, Axis Bank and HUL are among major losers.

Market bleeds: Sensex nosedives 630pts, Nifty sheds 198pts

Brokers said local traders were wary of buying at higher levels as foreign institutional investors do not appear too bullish at the moment.

Sensex, Nifty continue to struggle; rupee weakens to 64/USD

The Indian currency has weakened to 64 per dollar. The rupee fell to its lowest in 20 months on Thursday, weighed down by concerns over the government's taxation policies that threaten to reduce the allure of local assets for foreign institutions, while a global debt sell-off also hurt.

Sensex, Nifty under pressure; Dr Reddy up 3%, SBI falls

Dr Reddy's Labs, Reliance, HDFC Bank, Hero MotoCorp and HUL are top gainers in the Sensex. Among the top losers are Coal India, HDFC, Bharti Airtel, SBI and ICICI Bank.

Teva to gain post Ranbaxy's exclusivity loss for Nexium

Ranbaxy has lost out on its last big drug opportunity in the US market. The US drug regulator has denied the company 180-day exclusivity for the generic version of heart burn drug Nexium. However Archana Shukla reports that Ranbaxy's loss means good times for global rival Teva and Cipla.

Nifty struggles below 8300; oil & metal stocks drag

HUL, Infosys, Dr Reddy's Labs, Axis Bank and SBI are top gainers while Coal India, Reliance, Bajaj Auto and Hero are major laggards.

Nifty breaks 6250; BHEL falls 2%, pharma stocks weak

Ukraine's new PM has accused Russia of declaring war on the country. This is after Russia moved troops to three bases in Crimea on Sunday. The G7 has condemned Russia‘s intrusion into Ukraine and canceled preparations for the G8 summit that had been scheduled to take place in Sochi in June.